Search for:
Category

Product Regulation & Liability

Category
In Environment / Climate

Australia: ACCC to target ‘greenwashing’ online

by , , and 2 Mins Read

The ACCC has announced two internet sweeps to identify misleading environmental and sustainability marketing claims and fake or misleading online business reviews and a separate sweep to target fake or misleading online reviews and testimonials. The sweeps are being conducted as part of the ACCC’s compliance and enforcement priorities for 2022-23 announced earlier this year, with the broad aim of identifying deceptive advertising and marketing practices related to the environment and sustainability.

Read More
In Data Privacy

European Union: The European Health Data Space – A Trojan horse for pharma and medtech?

by 6 Mins Read

The draft European Health Data Space Regulation (EHDS) is flying under the radar for some industry players. It’s just one part of a tidal wave of EU data legislation coming down the track (including the Data Act, Data Governance Act and AI Act). This means it can easily get lost in the noise. But if you take a deeper look, the EHDS has some complex repercussions for a range of players; from pharma and medtech, to hospitals, public health bodies and even big tech. And not all of it is good news.

In Product Regulation & Liability

Argentina: Disposition No. 6924/2022 – Advertising of products with warning stamp

by , , and 3 Mins Read

The National Agency of Medicines, Food and Medical Technology (ANMAT) issued Disposition No. 6924/2022on 30 August 2022. The same provides some clarifications regarding the advertising, promotion and/or sponsorship of packaged food and nonalcoholic beverages containing at least one warning seal, including precautionary legends. The Disposition will take effect on the same day of its publication in the Official Gazette.

In Product Regulation & Liability

UK: Is the UK set to become an even bigger international player in medicinal and medical device regulation

by 2 Mins Read

The MHRA has been accepted as a full member of three groups: the International Medical Device Regulatory Forum (IMDRF), the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and the US-based Medical Devices Innovation Consortium. These partnerships bolster the MHRA’s position as an influential international player in medicinal and medical device regulation and restore the MHRA’s ties with the IMDRF and ICH.

In AML & Financial Services Regulatory

United States: Finally, an actual regulator steps into the cryptocurrency arena – NYS DFS issues stablecoin guidance

by , and 6 Mins Read

In the wake of last month’s collapse of the TerraUSD token, a broad array of regulators and government officials have attempted to introduce a legal framework around stablecoins. Last week, Senators Lummis and Gillibrand introduced a bill into the US Congress that would, among other things set requirements for the amount of backing assets stablecoin issuers would be required to hold.

Read More
In Product Regulation & Liability

Singapore: Updates to the HSA’s Software as a Medical Device regulatory framework

by 7 Mins Read

In April 2022, the Health Sciences Authority published its revised Regulatory Guidelines for Software Medical Devices. It has also finalised its new Guidelines on Risk Classification of Standalone Medical Mobile Applications and Qualification of Clinical Decision Software, which had been released for public consultation in July to August 2021.

Read More
Load More